MET and gastric cancer: Our study revealed that AFP-HSP90 inhibition increased the expression of c-Myc and c-Met, while AFP-HSP90 inhibition increased the sensitivity of gastric cancer cells to cisplatin and had an inhibitory effect on the expression of c-Myc and c-Met.